Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Health
|
Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.
|
Policies or Program
|
|
Health
|
Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.
|
Policies or Program
|
|
Health
|
Discussion on the opioids crisis and the Health minister's expectations from pharmaceutical manufacturers
|
Policies or Program
|
|
Health
|
Discussion regarding the launch of new branded product in the rare disease space
|
Policies or Program
|
|
Economic Development,
Research and Development,
Science and Technology,
Taxation and Finance
|
Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.
|
Policies or Program
|
|
Health
|
Policies aimed at facilitating generic drugs repurposing.
|
Policies or Program
|
|
Economic Development,
Health,
Industry
|
Policies aimed at reinforcing pharmaceutical supply chain.
|
Policies or Program
|
|
Defence,
Economic Development,
Health,
Industry
|
Seeking support from the Strategic Response Fund Program for support of biomanufacturing expansion project.
|
Grant, Contribution or Other Financial Benefit
|
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development,
Health,
Industry
|
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
|
Grant, Contribution or Other Financial Benefit
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
| Date | DPOH, Position Title | Government Institution | Subject Matters |
|---|---|---|
| 2025-08-21 |
|
Health |